Prot #PTI-801-01: A Multi-Center, Randomized, Placebo-Controlled, Phase 1, Two-Part Study Designed to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, an

Project: Research project

Project Details

StatusFinished
Effective start/end date9/26/179/26/20

Funding

  • Rho, Inc. (Prot #PTI-801-01)
  • Proteostasis Therapeutics, Inc. (Prot #PTI-801-01)